Innovotech Inc  

(Public, CVE:IOT)   Watch this stock  
Find more results for IOT
0.270
0.000 (0.00%)
Delayed:   3:50PM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.15 - 0.62
Open     -
Vol / Avg. 0.00/2,757.00
Mkt cap 7.39M
P/E     -
Div/yield     -
EPS -0.05
Shares 27.37M
Beta -0.02
Inst. own     -

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin -68.80% -108.18%
Operating margin -64.83% -106.34%
EBITD margin - -100.84%
Return on average assets -93.55% -88.58%
Return on average equity -321.86% -148.94%
Employees 16 -
Carbon Disclosure Rating - -

Address

Suite 101, 2011-94 Street.
Edmonton, AB T6N 1H1
Canada
+1-780-4480585 (Phone)
+1-780-4240941 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

Innovotech Inc. (Innovotech) is a biofilm product development, focused on providing solutions to medical, agricultural and industrial problems caused by microbial biofilms. Its products include human and veterinary biofilm susceptibility tests, a seed treatment designed to combat both bacterial and fungal diseases, and an assay used in growing microbial biofilms for research purposes. Innovotech has a range of products, which include commercially available products in three market segments: the MBEC Assay, bioFILM PA and the InnovoSCEPT veterinary tests for the research and development market, human health and veterinary markets respectively; and three products in advanced stages of development: the InnovoSCEPT human tests, Agress and Sani-Lux. The MBEC Assay is a throughput biofilm growth device. bioFILM PA is for treatment of patients with Pseudomonas aeruginosa infections. Innovotech has a pipeline of products targeting biofilm issues, including a second silver product, AgreGuard.

Officers and directors

Kerry Brown Independent Chairman of the Board
Kenneth Boutilier President, Chief Executive Officer
James Timourian Ph.D. Chief Financial Officer, Director
Bruce Darryl Hirsche Q.C. Corporate Secretary, Director
Age: 64
Bernard Grobbelaar Director
Lorne Babiuk Ph.D. Independent Director
Wolfgang Muhs Ph.D. Independent Director
Gerard Tertzakian Ph.D. Independent Director